Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, announced that...
Alzinova AB (publ) ("Alzinova" or "the Company"), announces that a second external safety review has been carried out of the Company's clinical phase 1b...
